Placement and a fully underwritten non-renounceable rights issue raising A$1.5m
Sep 05, 2016 - latest news
On Monday, 5th September 2016 Reproductive Health Science Ltd (“RHS or the “Company”) announced a placement of 7,000,000 shares at $0.075 per share, through Taylor Collison Limited, to sophisticated investors raising $525,000 before costs ("Placement") and a fully underwritten one (1) for five (5) non‐renounceable rights issue to raise approximately A$990,000 (before expenses) (“Rights Issue”). Investors participating in the Placement will be eligible to participate in the Rights Issue.
Full details of the Rights Issue is available in the Offer Memorandum and Appendix 3B lodged with ASX on 5th September 2016.